N

Nippon Shinyaku Co Ltd
TSE:4516

Watchlist Manager
Nippon Shinyaku Co Ltd
TSE:4516
Watchlist
Price: 5 796 JPY -2.98% Market Closed
Market Cap: 407.2B JPY

Operating Margin
Nippon Shinyaku Co Ltd

21.5%
Current
22%
Average
6.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
21.5%
=
Operating Profit
34.5B
/
Revenue
160.6B

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
JP
Nippon Shinyaku Co Ltd
TSE:4516
390.5B JPY
21%
US
Eli Lilly and Co
NYSE:LLY
965.2B USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
506.7B USD
27%
CH
Roche Holding AG
SIX:ROG
252.4B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
210.9B GBP
24%
CH
Novartis AG
SIX:NOVN
203.1B CHF
33%
US
Merck & Co Inc
NYSE:MRK
246.2B USD
38%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
42%
IE
Endo International PLC
LSE:0Y5F
202.5B USD
11%
US
Pfizer Inc
NYSE:PFE
147.5B USD
29%
No Stocks Found

Nippon Shinyaku Co Ltd
Glance View

Market Cap
390.5B JPY
Industry
Pharmaceuticals

Nippon Shinyaku Co., Ltd. stands as a beacon in the Japanese pharmaceutical landscape, weaving a story that begins over a century ago. Originally founded to address the medical needs of its society, the company has strategically evolved its focus, channeling its expertise into two main business domains: pharmaceuticals and functional food. As it carved its niche, Nippon Shinyaku harnessed the power of innovation and research to develop drugs that address critical medical needs, especially in oncology, hematology, and rare diseases. This specialization not only strengthens its foothold but also embodies a moral commitment to enhancing patient quality of life, proving profitable as these fields often present less competition but promise high demand and returns. Alongside its pharmaceutical ventures, Nippon Shinyaku has leveraged the burgeoning wellness trend through its functional food segment, offering products that promote health and prevent disease. This dual approach leverages the company's bioscience expertise and diversifies its revenue streams, shielding it from the volatility often seen in the pharmaceutical sector. By making strategic alliances and collaborations, both domestically and overseas, Nippon Shinyaku accelerates its market penetration and expands its international footprint. As it capitalizes on its robust R&D capabilities, the company anchors its success on a fusion of scientific advancement and strategic acumen, crafting a narrative of resilience and adaptability in a rapidly evolving industry.

Nippon Shinyaku Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
21.5%
=
Operating Profit
34.5B
/
Revenue
160.6B
What is the Operating Margin of Nippon Shinyaku Co Ltd?

Based on Nippon Shinyaku Co Ltd's most recent financial statements, the company has Operating Margin of 21.5%.

Back to Top